231 related articles for article (PubMed ID: 24264576)
1. GnRH-(1-5) transactivates EGFR in Ishikawa human endometrial cells via an orphan G protein-coupled receptor.
Cho-Clark M; Larco DO; Semsarzadeh NN; Vasta F; Mani SK; Wu TJ
Mol Endocrinol; 2014 Jan; 28(1):80-98. PubMed ID: 24264576
[TBL] [Abstract][Full Text] [Related]
2. GnRH-(1-5) activates matrix metallopeptidase-9 to release epidermal growth factor and promote cellular invasion.
Cho-Clark M; Larco DO; Zahn BR; Mani SK; Wu TJ
Mol Cell Endocrinol; 2015 Nov; 415():114-25. PubMed ID: 26277400
[TBL] [Abstract][Full Text] [Related]
3. Matrix metalloproteinases 2 and 9 mediate epidermal growth factor receptor transactivation by gonadotropin-releasing hormone.
Roelle S; Grosse R; Aigner A; Krell HW; Czubayko F; Gudermann T
J Biol Chem; 2003 Nov; 278(47):47307-18. PubMed ID: 12963732
[TBL] [Abstract][Full Text] [Related]
4. Heparin blockade of thrombin-induced smooth muscle cell migration involves inhibition of epidermal growth factor (EGF) receptor transactivation by heparin-binding EGF-like growth factor.
Kalmes A; Vesti BR; Daum G; Abraham JA; Clowes AW
Circ Res; 2000 Jul; 87(2):92-8. PubMed ID: 10903991
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin AT(1) and AT(2) receptors differentially regulate angiopoietin-2 and vascular endothelial growth factor expression and angiogenesis by modulating heparin binding-epidermal growth factor (EGF)-mediated EGF receptor transactivation.
Fujiyama S; Matsubara H; Nozawa Y; Maruyama K; Mori Y; Tsutsumi Y; Masaki H; Uchiyama Y; Koyama Y; Nose A; Iba O; Tateishi E; Ogata N; Jyo N; Higashiyama S; Iwasaka T
Circ Res; 2001 Jan; 88(1):22-9. PubMed ID: 11139469
[TBL] [Abstract][Full Text] [Related]
6. Roles of Src and epidermal growth factor receptor transactivation in transient and sustained ERK1/2 responses to gonadotropin-releasing hormone receptor activation.
Shah BH; Farshori MP; Jambusaria A; Catt KJ
J Biol Chem; 2003 May; 278(21):19118-26. PubMed ID: 12642580
[TBL] [Abstract][Full Text] [Related]
7. The role of GnRH metabolite, GnRH-(1-5), in endometrial cancer.
Cho-Clark MJ; Watkins A; Wu TJ
Front Endocrinol (Lausanne); 2023; 14():1183278. PubMed ID: 37124730
[TBL] [Abstract][Full Text] [Related]
8. Neuropeptide-induced transactivation of a neuronal epidermal growth factor receptor is mediated by metalloprotease-dependent formation of heparin-binding epidermal growth factor.
Shah BH; Farshori MP; Catt KJ
J Biol Chem; 2004 Jan; 279(1):414-20. PubMed ID: 14573593
[TBL] [Abstract][Full Text] [Related]
9. EGF receptor transactivation by urokinase receptor stimulus through a mechanism involving Src and matrix metalloproteinases.
Guerrero J; Santibañez JF; González A; Martínez J
Exp Cell Res; 2004 Jan; 292(1):201-8. PubMed ID: 14720519
[TBL] [Abstract][Full Text] [Related]
10. Antiproliferative signaling of luteinizing hormone-releasing hormone in human endometrial and ovarian cancer cells through G protein alpha(I)-mediated activation of phosphotyrosine phosphatase.
Gründker C; Völker P; Emons G
Endocrinology; 2001 Jun; 142(6):2369-80. PubMed ID: 11356684
[TBL] [Abstract][Full Text] [Related]
11. Regulation of type II luteinizing hormone-releasing hormone (LHRH-II) gene expression by the processed peptide of LHRH-I, LHRH-(1-5) in endometrial cells.
Baldwin EL; Wegorzewska IN; Flora M; Wu TJ
Exp Biol Med (Maywood); 2007 Jan; 232(1):146-55. PubMed ID: 17202595
[TBL] [Abstract][Full Text] [Related]
12. Transactivation of the epidermal growth factor receptor is involved in 12-O-tetradecanoylphorbol-13-acetate-induced signal transduction.
Chen N; Ma WY; She QB; Wu E; Liu G; Bode AM; Dong Z
J Biol Chem; 2001 Dec; 276(50):46722-8. PubMed ID: 11592962
[TBL] [Abstract][Full Text] [Related]
13. The bile acid receptor TGR5 does not interact with β-arrestins or traffic to endosomes but transmits sustained signals from plasma membrane rafts.
Jensen DD; Godfrey CB; Niklas C; Canals M; Kocan M; Poole DP; Murphy JE; Alemi F; Cottrell GS; Korbmacher C; Lambert NA; Bunnett NW; Corvera CU
J Biol Chem; 2013 Aug; 288(32):22942-60. PubMed ID: 23818521
[TBL] [Abstract][Full Text] [Related]
14. Leptin stimulates the proliferation of human oesophageal adenocarcinoma cells via HB-EGF and Tgfalpha mediated transactivation of the epidermal growth factor receptor.
Ogunwobi OO; Beales IL
Br J Biomed Sci; 2008; 65(3):121-7. PubMed ID: 18986098
[TBL] [Abstract][Full Text] [Related]
15. Intracellular signaling pathways mediated by the gonadotropin-releasing hormone (GnRH) receptor.
Kraus S; Naor Z; Seger R
Arch Med Res; 2001; 32(6):499-509. PubMed ID: 11750725
[TBL] [Abstract][Full Text] [Related]
16. TNF-α and LPA promote synergistic expression of COX-2 in human colonic myofibroblasts: role of LPA-mediated transactivation of upregulated EGFR.
Yoo J; Rodriguez Perez CE; Nie W; Sinnett-Smith J; Rozengurt E
BMC Gastroenterol; 2013 May; 13():90. PubMed ID: 23688423
[TBL] [Abstract][Full Text] [Related]
17. Gonadotropin-releasing hormone type II (GnRH-II) agonist regulates the invasiveness of endometrial cancer cells through the GnRH-I receptor and mitogen-activated protein kinase (MAPK)-dependent activation of matrix metalloproteinase (MMP)-2.
Wu HM; Wang HS; Huang HY; Lai CH; Lee CL; Soong YK; Leung PC
BMC Cancer; 2013 Jun; 13():300. PubMed ID: 23786715
[TBL] [Abstract][Full Text] [Related]
18. Luteinizing hormone-releasing hormone I (LHRH-I) and its metabolite in peripheral tissues.
Walters K; Wegorzewska IN; Chin YP; Parikh MG; Wu TJ
Exp Biol Med (Maywood); 2008 Feb; 233(2):123-30. PubMed ID: 18222967
[TBL] [Abstract][Full Text] [Related]
19. Insulin-induced epidermal growth factor activation in vascular smooth muscle cells is ADAM-dependent.
Roztocil E; Nicholl SM; Davies MG
Surgery; 2008 Aug; 144(2):245-51. PubMed ID: 18656632
[TBL] [Abstract][Full Text] [Related]
20. Dependence of gonadotropin-releasing hormone-induced neuronal MAPK signaling on epidermal growth factor receptor transactivation.
Shah BH; Soh JW; Catt KJ
J Biol Chem; 2003 Jan; 278(5):2866-75. PubMed ID: 12446705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
